222 related articles for article (PubMed ID: 16061255)
21. Characterization of two novel proteins, NgRH1 and NgRH2, structurally and biochemically homologous to the Nogo-66 receptor.
Pignot V; Hein AE; Barske C; Wiessner C; Walmsley AR; Kaupmann K; Mayeur H; Sommer B; Mir AK; Frentzel S
J Neurochem; 2003 May; 85(3):717-28. PubMed ID: 12694398
[TBL] [Abstract][Full Text] [Related]
22. Nogo on the go.
McKerracher L; Winton MJ
Neuron; 2002 Oct; 36(3):345-8. PubMed ID: 12408839
[TBL] [Abstract][Full Text] [Related]
23. Ganglioside mediate the interaction between Nogo receptor 1 and LINGO-1.
Saha N; Kolev MV; Semavina M; Himanen J; Nikolov DB
Biochem Biophys Res Commun; 2011 Sep; 413(1):92-7. PubMed ID: 21872576
[TBL] [Abstract][Full Text] [Related]
24. Altered expression of myelin-associated inhibitors and their receptors after traumatic brain injury in the mouse.
Israelsson C; Flygt J; Åstrand E; Kiwanuka O; Bengtsson H; Marklund N
Restor Neurol Neurosci; 2014; 32(5):717-31. PubMed ID: 25079982
[TBL] [Abstract][Full Text] [Related]
25. Nogos and the Nogo-66 receptor: factors inhibiting CNS neuron regeneration.
Ng CE; Tang BL
J Neurosci Res; 2002 Mar; 67(5):559-65. PubMed ID: 11891768
[TBL] [Abstract][Full Text] [Related]
26. Zinc metalloproteinase-mediated cleavage of the human Nogo-66 receptor.
Walmsley AR; McCombie G; Neumann U; Marcellin D; Hillenbrand R; Mir AK; Frentzel S
J Cell Sci; 2004 Sep; 117(Pt 19):4591-602. PubMed ID: 15331667
[TBL] [Abstract][Full Text] [Related]
27. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1.
Niederöst B; Oertle T; Fritsche J; McKinney RA; Bandtlow CE
J Neurosci; 2002 Dec; 22(23):10368-76. PubMed ID: 12451136
[TBL] [Abstract][Full Text] [Related]
28. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.
Li S; Liu BP; Budel S; Li M; Ji B; Walus L; Li W; Jirik A; Rabacchi S; Choi E; Worley D; Sah DW; Pepinsky B; Lee D; Relton J; Strittmatter SM
J Neurosci; 2004 Nov; 24(46):10511-20. PubMed ID: 15548666
[TBL] [Abstract][Full Text] [Related]
29. NgR acts as an inhibitor to axonal regeneration in adults.
Zhang S; Zhang Q; Zhang JH; Qin X
Front Biosci; 2008 Jan; 13():2030-40. PubMed ID: 17981689
[TBL] [Abstract][Full Text] [Related]
30. [Preparation and identification of rabbit antibody against LRR of Nogo-66 receptor (NgR)].
Yu PP; Zhu HQ; Lu PH; Huang LD
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep; 22(5):633-5. PubMed ID: 16948913
[TBL] [Abstract][Full Text] [Related]
31. Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA.
Schweigreiter R; Walmsley AR; Niederöst B; Zimmermann DR; Oertle T; Casademunt E; Frentzel S; Dechant G; Mir A; Bandtlow CE
Mol Cell Neurosci; 2004 Oct; 27(2):163-74. PubMed ID: 15485772
[TBL] [Abstract][Full Text] [Related]
32. Nogo and Nogo receptor: relevance to schizophrenia?
Willi R; Schwab ME
Neurobiol Dis; 2013 Jun; 54():150-7. PubMed ID: 23369871
[TBL] [Abstract][Full Text] [Related]
33. Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury.
Walmsley AR; Mir AK
Curr Pharm Des; 2007; 13(24):2470-84. PubMed ID: 17692015
[TBL] [Abstract][Full Text] [Related]
34. Two novel mammalian Nogo receptor homologs differentially expressed in the central and peripheral nervous systems.
Laurén J; Airaksinen MS; Saarma M; Timmusk T
Mol Cell Neurosci; 2003 Nov; 24(3):581-94. PubMed ID: 14664809
[TBL] [Abstract][Full Text] [Related]
35. Alpha tocopherol treatment reduces the expression of Nogo-A and NgR in rat brain after traumatic brain injury.
Yang J; Han Y; Ye W; Liu F; Zhuang K; Wu G
J Surg Res; 2013 Jun; 182(2):e69-77. PubMed ID: 23207171
[TBL] [Abstract][Full Text] [Related]
36. The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein.
Venkatesh K; Chivatakarn O; Lee H; Joshi PS; Kantor DB; Newman BA; Mage R; Rader C; Giger RJ
J Neurosci; 2005 Jan; 25(4):808-22. PubMed ID: 15673660
[TBL] [Abstract][Full Text] [Related]
37. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth.
Domeniconi M; Cao Z; Spencer T; Sivasankaran R; Wang K; Nikulina E; Kimura N; Cai H; Deng K; Gao Y; He Z; Filbin M
Neuron; 2002 Jul; 35(2):283-90. PubMed ID: 12160746
[TBL] [Abstract][Full Text] [Related]
38. Nogo receptor 3, a paralog of Nogo-66 receptor 1 (NgR1), may function as a NgR1 co-receptor for Nogo-66.
Zhang L; Kuang X; Zhang J
J Genet Genomics; 2011 Nov; 38(11):515-23. PubMed ID: 22133682
[TBL] [Abstract][Full Text] [Related]
39. Differential expression patterns of messenger RNAs encoding Nogo receptors and their ligands in the rat central nervous system.
Funahashi S; Hasegawa T; Nagano A; Sato K
J Comp Neurol; 2008 Jan; 506(1):141-60. PubMed ID: 17990276
[TBL] [Abstract][Full Text] [Related]
40. Detection of anti-Nogo receptor autoantibody in the serum of multiple sclerosis and controls.
Onoue H; Satoh JI; Ogawa M; Tabunoki H; Yamamura T
Acta Neurol Scand; 2007 Mar; 115(3):153-60. PubMed ID: 17295709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
